Three adverse event reports appear in the FDAs FAERS database through December 2025, all involving injectable product and none clearly attributable to BPC-157 itself. Whats missing is scale
Normally, this GSSG is recycled by reductases to maintain sufficient intracellular levels of reduced GSH
More importantly, if you are using a 1 mL (100 unit) syringe, there is very little room for higher doses
You need to dissolve it in a sterile liquid to create an injectable solution, and that process is called reconstitution
It is recognized for its capacity to speed up the repair of tissues of the digestive system and muscles
Critically, and this is the connection to NAD+ that matters for stacking, according to the foundational 2016 PMC paper by Lee et al